Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on a National Strategy for the Elimination of Hepatitis B and C
Brian L. Strom, Gillian J. Buckley
, editors.
Washington (DC): National Academies Press (US); 2017 Mar 28.
Free Books & Documents
Review

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

National Academies of Sciences, Engineering, and Medicine et al.
Free Books & Documents

Excerpt

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide.

The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them.

PubMed Disclaimer

Similar articles

  • Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report.
    Committee on a National Strategy for the Elimination of Hepatitis B and C; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine; Buckley GJ, Strom BL, editors. Committee on a National Strategy for the Elimination of Hepatitis B and C, et al. Washington (DC): National Academies Press (US); 2016 Jun 1. Washington (DC): National Academies Press (US); 2016 Jun 1. PMID: 27336113 Free Books & Documents. Review.
  • China's efforts to shed its title of "Leader in liver disease".
    Li X, Xu WF. Li X, et al. Drug Discov Ther. 2007 Oct;1(2):84-5. Drug Discov Ther. 2007. PMID: 22504391
  • A brief history of hepatitis milestones.
    Trepo C. Trepo C. Liver Int. 2014 Feb;34 Suppl 1:29-37. doi: 10.1111/liv.12409. Liver Int. 2014. PMID: 24373076 Review.
  • A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. Goldstein ST, et al. Int J Epidemiol. 2005 Dec;34(6):1329-39. doi: 10.1093/ije/dyi206. Epub 2005 Oct 25. Int J Epidemiol. 2005. PMID: 16249217
  • Viral Hepatitis.
    Wiktor SZ. Wiktor SZ. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 16. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 16. PMID: 30212098 Free Books & Documents. Review.
See all similar articles

Grants and funding

This activity was supported by the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America, the National Viral Hepatitis Roundtable, and the U.S. Department of Health and Human Services/Centers for Disease Control and Prevention (Contract No. 200-2011-38807, Task Order #44). Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.

LinkOut - more resources